NCG Small Cap Growth Strategy

Investor Summary

Next Century Growth Investors was founded in November 1998 by Tom Press, CFA, who serves as Chairman, Portfolio Manager, and Partner. The firm is led by a seasoned management team including Bob Scott, CFA as CEO (joined 2000), Peter Capouch, CFA as President (joined 2003), Kaj Doerring as Portfolio Manager and Partner (joined 2005), and Tom Dignard, CFA as Portfolio Manager and Partner (joined 2013). The team has over 100 years combined investment experience working together at NCG. The firm is 80% owned by its active portfolio manager partners, maintaining independence and control over operations and investments. The partners have invested significant personal capital in the firm and into investment portfolios which are identical to the ones they manage for clients.

Fund Strategy

NCG seeks to generate long-term capital appreciation by investing in the fastest-growing and highest-quality companies in the US small cap growth universe. The firm believes the market inefficiently values high-quality companies with long-term growth opportunities. They employ a bottom-up fundamental research approach with diversified portfolios of 40-60 holdings, applying strict position and sector limits to manage risk. The investment process is team-based, involving collaborative research, quarterly growth screenings, extensive engagement with management teams, and fundamental financial analysis. The firm believes that a portfolio consisting of high-quality growth companies, combined with a strong sell discipline, will lead to both compounding of portfolio value and better performance than the unmanaged index over the long-term.

ANNUALIZED SINCE INCEPTION	QUARTERLY	YTD
10.61%	-2.09%	-2.09%

Executive Summary

Next Century Growth Investors delivered solid relative performance in 1Q26 despite broad market volatility driven by geopolitical tensions and energy supply disruptions. The firm's small cap strategy outperformed benchmarks by focusing on high-quality growth companies with strong fundamentals. Key contributors included AI infrastructure investments spanning semiconductors, optical components, and data center buildout, which benefited from robust spending on computing capacity and networking. Aerospace and defense holdings also performed well, supported by elevated global defense spending and growing order backlogs. The portfolio added 12 new positions while exiting 15, maintaining overweight positions in technology, industrials, and basic materials. Looking ahead, the manager sees favorable conditions for continued market broadening, particularly in small caps where earnings growth has turned positive and valuations remain attractive relative to large caps. Federal Reserve easing and improving business fundamentals support the outlook. The firm believes this environment reinforces the value of active management and disciplined stock selection focused on companies with sustainable competitive advantages.

Forward Outlook

The investment environment presents a mix of near-term uncertainties and longer-term opportunities. U.S. economic growth remains resilient, supported by steady consumer spending, improving earnings trends, and the lagged benefits of monetary easing. Conditions remain favorable for continued market broadening. This environment reinforces the value of active management and fundamental research.

Date	Letter	Tickers	Keywords	Pitches	Quick Takes
Apr 22 2026	2026 Q1	-	AI Infrastructure, defense, growth, industrials, semiconductors, small cap, technology	-	NCG's small cap growth strategy outperformed in volatile 1Q26 by focusing on AI infrastructure, defense, and quality growth companies. Strong performance from semiconductors, optical components, and aerospace holdings offset geopolitical headwinds. Small cap fundamentals improving with positive earnings growth and attractive valuations versus large caps. Fed easing and market broadening create favorable environment for selective stock picking.
Jan 21 2026	2025 Q4	ADPT, ATEC, AVPT, AXGN, BETA, BLND, CCB, CELH, COHR, ELF, KNX, KVYO, MTSI, PCOR, PEGA, PI, PRCH, QTWO, TOL, TTAN, UTI, WAL, WULF	active management, growth, healthcare, industrials, Outperformance, Quality, small caps, technology	-	NCG's small cap growth strategy faced headwinds in 2025 as quality factors worked against active managers, with low-quality stocks significantly outperforming their high-quality holdings. Despite relative underperformance, they maintain conviction in their disciplined approach and see improving conditions ahead with positive small cap earnings growth, Fed rate cuts, and attractive relative valuations supporting future outperformance.
Oct 24 2025	2025 Q3	AAON, ADMA, AEHR, APLD, AVAV, BE, CDNA, FROG, KVYO, LEU, MIRM, MP, PAR, PGY, PI, PL, PRCH, STRL, TOL, VCEL, XMTR	AI, defense, growth, infrastructure, nuclear, small cap, Speculation, valuation	XMTR BE	NCG's Small Cap Growth strategy underperformed in 3Q25 as speculative, low-quality stocks drove index returns while traditional growth areas lagged. The firm maintains discipline in high-quality companies with strong fundamentals, positioning for long-term outperformance. With Fed rate cuts, improving earnings outlook, and historically cheap small cap valuations, significant catch-up potential exists for quality growth stocks.
Aug 7 2025	2025 Q2	AAON, AGYS, ALHC, AVPT, CDNA, CELH, CRS, CWK, ELF, GDYN, GWRE, HXL, INOD, MTSI, RXST, SAIA, SPRY, STRL, TMDX, TTAN	growth, healthcare, infrastructure, rates, small cap, technology, Trade Policy	-	NCG outperformed across most strategies in 2Q25 despite initial tariff-related volatility. The firm maintains overweight positions in technology, healthcare, and materials while adding eight new positions. With small caps at historically attractive valuations versus large caps and potential Fed rate cuts ahead, NCG sees significant opportunity in high-quality growth companies.
Mar 31 2025	2025 Q1	AGYS, ALHC, ATRO, BROS, CAVA, ELF, FLYW, FRPT, GLBE, INOD, IRTC, OS, PEGA, PEN, PYCR, QNST, SAIA, SDHC, SITM, VERX	earnings, growth, healthcare, industrials, policy, small cap, technology, Valuations	-	NCG's small cap growth strategy declined 12.99% in Q1 2025, underperforming due to technology and industrials exposure amid policy uncertainty from the new administration. The firm actively repositioned the portfolio, adding five new positions while eliminating 14 underperformers. Despite near-term headwinds, NCG sees attractive valuations and maintains conviction in their quality growth approach for long-term outperformance.
Dec 31 2023	2023 Q4	BRZE, CSTL, CWAN, DAVA, FLYW, GWRE, KNSL, LGIH, MEDP, NTRA, SILK, TMDX, TNDM, VRRM	Biotechnology, Fed Pivot, growth, healthcare, market breadth, small caps	MEDP BRZE ACGL\|APH\|COO\|CSGP\|DKNG\|GWRE\|IDXX\|IOT\|IT\|LPLA\|MSCI\|MTD\|PCOR\|ROP\|TECH\|VRSK ARGX BB\|DAVA\|DDOG\|GLOB\|ILMN\|LOAR\|MELI\|NET\|NU\|NVDA\|TSM NTRA ASIC\|CWAN\|INSP\|KRMN\|KTOS\|MAC\|MEG\|RH\|WYNN TNDM CSTL	NCG's Small Cap Growth strategy returned 4.75% in Q4 but underperformed for the full year at 14.83% versus the Russell 2000 Growth's 18.65%. Healthcare holdings weighed on performance due to GLP-1 concerns, though the Fed pivot drove small cap outperformance late in the quarter. The firm added eight new positions while maintaining their disciplined growth approach.

Date

Letter

Tickers

Keywords

Pitches

Quick Takes

Apr 22 2026

2026 Q1

AI Infrastructure, defense, growth, industrials, semiconductors, small cap, technology

NCG's small cap growth strategy outperformed in volatile 1Q26 by focusing on AI infrastructure, defense, and quality growth companies. Strong performance from semiconductors, optical components, and aerospace holdings offset geopolitical headwinds. Small cap fundamentals improving with positive earnings growth and attractive valuations versus large caps. Fed easing and market broadening create favorable environment for selective stock picking.

Jan 21 2026

2025 Q4

ADPT, ATEC, AVPT, AXGN, BETA, BLND, CCB, CELH, COHR, ELF, KNX, KVYO, MTSI, PCOR, PEGA, PI, PRCH, QTWO, TOL, TTAN, UTI, WAL, WULF

active management, growth, healthcare, industrials, Outperformance, Quality, small caps, technology

NCG's small cap growth strategy faced headwinds in 2025 as quality factors worked against active managers, with low-quality stocks significantly outperforming their high-quality holdings. Despite relative underperformance, they maintain conviction in their disciplined approach and see improving conditions ahead with positive small cap earnings growth, Fed rate cuts, and attractive relative valuations supporting future outperformance.

Oct 24 2025

2025 Q3

AAON, ADMA, AEHR, APLD, AVAV, BE, CDNA, FROG, KVYO, LEU, MIRM, MP, PAR, PGY, PI, PL, PRCH, STRL, TOL, VCEL, XMTR

AI, defense, growth, infrastructure, nuclear, small cap, Speculation, valuation

XMTR
BE

NCG's Small Cap Growth strategy underperformed in 3Q25 as speculative, low-quality stocks drove index returns while traditional growth areas lagged. The firm maintains discipline in high-quality companies with strong fundamentals, positioning for long-term outperformance. With Fed rate cuts, improving earnings outlook, and historically cheap small cap valuations, significant catch-up potential exists for quality growth stocks.

Aug 7 2025

2025 Q2

AAON, AGYS, ALHC, AVPT, CDNA, CELH, CRS, CWK, ELF, GDYN, GWRE, HXL, INOD, MTSI, RXST, SAIA, SPRY, STRL, TMDX, TTAN

growth, healthcare, infrastructure, rates, small cap, technology, Trade Policy

NCG outperformed across most strategies in 2Q25 despite initial tariff-related volatility. The firm maintains overweight positions in technology, healthcare, and materials while adding eight new positions. With small caps at historically attractive valuations versus large caps and potential Fed rate cuts ahead, NCG sees significant opportunity in high-quality growth companies.

Mar 31 2025

2025 Q1

AGYS, ALHC, ATRO, BROS, CAVA, ELF, FLYW, FRPT, GLBE, INOD, IRTC, OS, PEGA, PEN, PYCR, QNST, SAIA, SDHC, SITM, VERX

earnings, growth, healthcare, industrials, policy, small cap, technology, Valuations

NCG's small cap growth strategy declined 12.99% in Q1 2025, underperforming due to technology and industrials exposure amid policy uncertainty from the new administration. The firm actively repositioned the portfolio, adding five new positions while eliminating 14 underperformers. Despite near-term headwinds, NCG sees attractive valuations and maintains conviction in their quality growth approach for long-term outperformance.

Dec 31 2023

2023 Q4

BRZE, CSTL, CWAN, DAVA, FLYW, GWRE, KNSL, LGIH, MEDP, NTRA, SILK, TMDX, TNDM, VRRM

Biotechnology, Fed Pivot, growth, healthcare, market breadth, small caps

NCG's Small Cap Growth strategy returned 4.75% in Q4 but underperformed for the full year at 14.83% versus the Russell 2000 Growth's 18.65%. Healthcare holdings weighed on performance due to GLP-1 concerns, though the Fed pivot drove small cap outperformance late in the quarter. The firm added eight new positions while maintaining their disciplined growth approach.

QUARTER	THEMES	TAGS
2026 Q1	AI Investments tied to AI infrastructure, including semiconductors, optical components, power buildout and site development, performed well as spending on computing capacity, networking, and data-center build-outs remained robust. Technology performance was driven by semiconductors, optical components, and test equipment holdings.	Infrastructure Semiconductors Data Centers Computing Networking
	Defense Spending Aerospace and defense holdings contributed positively, supported by elevated global defense spending and growing order backlogs. The portfolio is overweight in the industrial sector with holdings in aerospace & defense areas.	Aerospace Defense Order Backlogs Global Spending
	Small Caps Small cap earnings growth turned positive during 2025 and is expected to stay positive and potentially accelerate in 2026. Small cap stocks continue to trade at attractive valuations relative to large cap stocks. Combined with an improving fundamental backdrop, this presents further opportunities in small caps.	Earnings Growth Valuations Fundamentals Opportunities
	Critical Minerals The portfolio is overweight basic materials with holdings consisting of companies in the rare/critical minerals market. Basic materials performance was driven by critical minerals and aerospace holdings.	Basic Materials Rare Minerals Supply Demand
2025 Q4	AI Manager discusses AI monetization progress at Alphabet with strong third-quarter results and improving sentiment around digital advertising and AI. Google Cloud grew over 30% year-over-year supported by rapid adoption of AI training and inference services. Alphabet introduced several Gemini platform enhancements during the quarter including lower-cost inference options.	Cloud Monetization Infrastructure Training Inference
	Cloud Google Cloud performance highlighted as a key driver with over 30% year-over-year growth supported by rapid adoption of AI training and inference services. Manager views cloud infrastructure as creating substantial growth opportunities for Alphabet with scale and data advantages.	Infrastructure Growth Services Adoption
	Pharmaceuticals Eli Lilly was a top performer driven by strong Q3 2025 earnings with revenue rising 54% year-over-year. Growth was driven by GLP-1 franchises Mounjaro and Zepbound where sales more than doubled. Manager believes Lilly remains one of the highest-quality growth franchises in global healthcare with leadership in diabetes, obesity, and neuroscience.	GLP1 Diabetes Obesity Growth
	Medical Devices Intuitive Surgical delivered strong Q3 results with procedure volumes rising in mid-teens globally and notable strength in general surgery and urology. Manager views ISRG as the clear leader in robotic-assisted surgery with a deep installed base, high recurring revenue, and decades of clinical data supporting continued adoption.	Robotics Surgery Procedures Recurring
	Streaming Netflix was the portfolio's largest detractor following investor concerns around near-term subscriber growth and rising content spending. While revenue grew approximately 10% year-over-year, management guided to slower net subscriber additions after recent price increases. Despite headwinds, manager continues to view Netflix as the dominant global streaming platform with durable competitive advantages.	Content Subscribers Competition Global
2025 Q3	AI Artificial intelligence presents great promise for enhancing business models and improving productivity long-term. In the near-term, the infrastructure needed to support the AI buildout is spurring significant increases in investment and capital expenditures, driving new growth opportunities for innovative companies across technology, industrials, and energy sectors.	Infrastructure Productivity Technology Investment Growth
	Infrastructure Spending The new administration has implemented pro-growth policies including infrastructure spending, manufacturing re-shoring, critical mineral and pharmaceutical production, and defense spending. These policies are expected to support growth across many sectors of the domestic economy and create direct beneficiaries among portfolio companies.	Manufacturing Defense Domestic Policy Growth
	Critical Minerals Critical minerals emerged as one of the significant rally areas in micro and small cap indices during 3Q25. The portfolio maintains exposure through a company in the rare earth materials market as part of their basic materials overweight, though many companies in this space have elevated valuations relative to business fundamentals.	Rare Earths Materials Valuation Rally Exposure
	Nuclear Nuclear energy was identified as one of the areas with big gainers and material contribution to the micro and small cap indices during 3Q25. This represents part of the broader speculative rally in emerging growth areas, though business fundamentals may not support extremely elevated valuation levels in many cases.	Energy Speculative Valuation Rally Growth
	Defense Defense and space emerged as significant contributors to index performance in 3Q25, with the portfolio adding AeroVironment as a new position. The administration's pro-growth policies include increased defense spending, creating opportunities for companies in this sector.	Space Spending Policy Growth Opportunity
2025 Q2	Small Caps Small cap growth stocks participated in the recent market rally, but further opportunity exists. The rolling 10-year annualized return by small vs large stands at -7.3% and is the worst ever going back to 1926, and the valuation of the small cap sector relative to large caps is in the 5th percentile historically.	Small Cap Valuation Relative Performance Growth Opportunity
	Trade Policy The quarter was marked by a swift selloff in early April following President Trump's Liberation Day tariff announcement on April 2nd. However, a week after Liberation Day, the administration put in place a 90-day pause on tariff implementation and started talking about numerous ongoing trade deal negotiations.	Tariffs Trade Deals Policy Uncertainty Implementation Negotiations
	Infrastructure Spending Strong forces driving increased infrastructure spending in the US have been gaining momentum for the past couple years and remain intact. The new administration is working to accelerate this trend and we are finding companies which are direct beneficiaries.	Infrastructure Government Spending Beneficiaries Acceleration Momentum
	Rates The Federal Reserve has held rates unchanged so far in 2025 following rate cuts totaling 100bps in the back half of 2024. The Fed remains committed to evaluating the incoming data to determine the path of future rate decisions but has recently signaled a willingness to cut rates at some point this year.	Federal Reserve Rate Cuts Monetary Policy Data Dependent 2025
2025 Q1	Infrastructure Spending Strong forces driving increased infrastructure spending in the US have been gaining momentum for the past couple years and remain intact. The new administration is working to accelerate this trend and NCG is finding small companies which are direct beneficiaries.	Infrastructure Government Construction Spending Policy
	Trade Policy The new US administration has not solidified its go-forward international trade and tariff policies. While the market seems to be assuming the worst, the administration has recently been reflecting more flexibility in its approach, and NCG believes the final policy may not be as draconian as feared.	Tariffs Trade Policy International Administration
2023 Q4	Small Caps Small cap stocks underperformed large caps heading into the fourth quarter, with the Russell Microcap Growth Index down about 5% through Q3. However, market breadth broadened in November and December following the Fed pivot, with the Russell Microcap Growth Index returning 13.68% versus 4.42% for large caps. The rally was primarily led by low quality stocks and sectors most impacted by the Fed's restrictive stance.	Small Cap Russell 2000 Microcap Market Breadth Fed Pivot
	Biotechnology Healthcare holdings drove much of the underperformance across strategies due to investor perception that GLP-1 weight loss drugs will improve overall health and reduce medical interventions. Many healthcare companies began to recover in Q4, and the firm still believes in long-term growth fundamentals despite the negative sentiment around the sector.	Healthcare GLP-1 Medical Devices Biotech Drug Development
	Growth The firm continues to focus on investing in what they believe are the fastest growing and highest quality companies in America. They emphasize owning companies that can grow revenue and profits at strong rates in any economic environment, maintaining their philosophy of bottom-up stock picking and strong sell discipline.	Growth Investing Revenue Growth Quality Companies Stock Selection Sell Discipline

QUARTER

THEMES

AI

Investments tied to AI infrastructure, including semiconductors, optical components, power buildout and site development, performed well as spending on computing capacity, networking, and data-center build-outs remained robust. Technology performance was driven by semiconductors, optical components, and test equipment holdings.

Infrastructure Semiconductors Data Centers Computing Networking

Defense Spending

Aerospace and defense holdings contributed positively, supported by elevated global defense spending and growing order backlogs. The portfolio is overweight in the industrial sector with holdings in aerospace & defense areas.

Aerospace Defense Order Backlogs Global Spending

Small Caps

Small cap earnings growth turned positive during 2025 and is expected to stay positive and potentially accelerate in 2026. Small cap stocks continue to trade at attractive valuations relative to large cap stocks. Combined with an improving fundamental backdrop, this presents further opportunities in small caps.

Earnings Growth Valuations Fundamentals Opportunities

Critical Minerals

The portfolio is overweight basic materials with holdings consisting of companies in the rare/critical minerals market. Basic materials performance was driven by critical minerals and aerospace holdings.

Basic Materials Rare Minerals Supply Demand

2025 Q4

AI

Manager discusses AI monetization progress at Alphabet with strong third-quarter results and improving sentiment around digital advertising and AI. Google Cloud grew over 30% year-over-year supported by rapid adoption of AI training and inference services. Alphabet introduced several Gemini platform enhancements during the quarter including lower-cost inference options.

Cloud Monetization Infrastructure Training Inference

Cloud

Google Cloud performance highlighted as a key driver with over 30% year-over-year growth supported by rapid adoption of AI training and inference services. Manager views cloud infrastructure as creating substantial growth opportunities for Alphabet with scale and data advantages.

Infrastructure Growth Services Adoption

Pharmaceuticals

Eli Lilly was a top performer driven by strong Q3 2025 earnings with revenue rising 54% year-over-year. Growth was driven by GLP-1 franchises Mounjaro and Zepbound where sales more than doubled. Manager believes Lilly remains one of the highest-quality growth franchises in global healthcare with leadership in diabetes, obesity, and neuroscience.

GLP1 Diabetes Obesity Growth

Medical Devices

Intuitive Surgical delivered strong Q3 results with procedure volumes rising in mid-teens globally and notable strength in general surgery and urology. Manager views ISRG as the clear leader in robotic-assisted surgery with a deep installed base, high recurring revenue, and decades of clinical data supporting continued adoption.

Robotics Surgery Procedures Recurring

Streaming

Netflix was the portfolio's largest detractor following investor concerns around near-term subscriber growth and rising content spending. While revenue grew approximately 10% year-over-year, management guided to slower net subscriber additions after recent price increases. Despite headwinds, manager continues to view Netflix as the dominant global streaming platform with durable competitive advantages.

Content Subscribers Competition Global

2025 Q3

AI

Artificial intelligence presents great promise for enhancing business models and improving productivity long-term. In the near-term, the infrastructure needed to support the AI buildout is spurring significant increases in investment and capital expenditures, driving new growth opportunities for innovative companies across technology, industrials, and energy sectors.

Infrastructure Productivity Technology Investment Growth

Infrastructure Spending

The new administration has implemented pro-growth policies including infrastructure spending, manufacturing re-shoring, critical mineral and pharmaceutical production, and defense spending. These policies are expected to support growth across many sectors of the domestic economy and create direct beneficiaries among portfolio companies.

Manufacturing Defense Domestic Policy Growth

Critical Minerals

Critical minerals emerged as one of the significant rally areas in micro and small cap indices during 3Q25. The portfolio maintains exposure through a company in the rare earth materials market as part of their basic materials overweight, though many companies in this space have elevated valuations relative to business fundamentals.

Rare Earths Materials Valuation Rally Exposure

Nuclear

Nuclear energy was identified as one of the areas with big gainers and material contribution to the micro and small cap indices during 3Q25. This represents part of the broader speculative rally in emerging growth areas, though business fundamentals may not support extremely elevated valuation levels in many cases.

Energy Speculative Valuation Rally Growth

Defense

Defense and space emerged as significant contributors to index performance in 3Q25, with the portfolio adding AeroVironment as a new position. The administration's pro-growth policies include increased defense spending, creating opportunities for companies in this sector.

Space Spending Policy Growth Opportunity

2025 Q2

Small Caps

Small cap growth stocks participated in the recent market rally, but further opportunity exists. The rolling 10-year annualized return by small vs large stands at -7.3% and is the worst ever going back to 1926, and the valuation of the small cap sector relative to large caps is in the 5th percentile historically.

Small Cap Valuation Relative Performance Growth Opportunity

Trade Policy

The quarter was marked by a swift selloff in early April following President Trump's Liberation Day tariff announcement on April 2nd. However, a week after Liberation Day, the administration put in place a 90-day pause on tariff implementation and started talking about numerous ongoing trade deal negotiations.

Tariffs Trade Deals Policy Uncertainty Implementation Negotiations

Infrastructure Spending

Strong forces driving increased infrastructure spending in the US have been gaining momentum for the past couple years and remain intact. The new administration is working to accelerate this trend and we are finding companies which are direct beneficiaries.

Infrastructure Government Spending Beneficiaries Acceleration Momentum

Rates

The Federal Reserve has held rates unchanged so far in 2025 following rate cuts totaling 100bps in the back half of 2024. The Fed remains committed to evaluating the incoming data to determine the path of future rate decisions but has recently signaled a willingness to cut rates at some point this year.

Federal Reserve Rate Cuts Monetary Policy Data Dependent 2025

2025 Q1

Infrastructure Spending

Strong forces driving increased infrastructure spending in the US have been gaining momentum for the past couple years and remain intact. The new administration is working to accelerate this trend and NCG is finding small companies which are direct beneficiaries.

Infrastructure Government Construction Spending Policy

Trade Policy

The new US administration has not solidified its go-forward international trade and tariff policies. While the market seems to be assuming the worst, the administration has recently been reflecting more flexibility in its approach, and NCG believes the final policy may not be as draconian as feared.

Tariffs Trade Policy International Administration

2023 Q4

Small Caps

Small cap stocks underperformed large caps heading into the fourth quarter, with the Russell Microcap Growth Index down about 5% through Q3. However, market breadth broadened in November and December following the Fed pivot, with the Russell Microcap Growth Index returning 13.68% versus 4.42% for large caps. The rally was primarily led by low quality stocks and sectors most impacted by the Fed's restrictive stance.

Small Cap Russell 2000 Microcap Market Breadth Fed Pivot

Biotechnology

Healthcare holdings drove much of the underperformance across strategies due to investor perception that GLP-1 weight loss drugs will improve overall health and reduce medical interventions. Many healthcare companies began to recover in Q4, and the firm still believes in long-term growth fundamentals despite the negative sentiment around the sector.

Healthcare GLP-1 Medical Devices Biotech Drug Development

Growth

The firm continues to focus on investing in what they believe are the fastest growing and highest quality companies in America. They emphasize owning companies that can grow revenue and profits at strong rates in any economic environment, maintaining their philosophy of bottom-up stock picking and strong sell discipline.

Growth Investing Revenue Growth Quality Companies Stock Selection Sell Discipline

Date	Pitch Type	Author	Ticker	Company	Industry	Sub Industry	Bull / Bear	Exchange	Keywords	Action
Oct 24, 2025	Fund Letters	Tom Press	XMTR	Xometry Inc.	Industrials	Commercial Services & Supplies	Bull	NASDAQ	AI, Automation, Digitization, growth, manufacturing, Margins, marketplace, Partnerships, Reshoring, supply chain	Login
Oct 24, 2025	Fund Letters	Tom Press	BE	Bloom Energy Corporation	Industrials	Renewable Electricity	Bull	NYSE	AI, backlog, energy, Fuel cells, growth, hyperscalers, infrastructure, Margins, Power, renewables	Login
Dec 31, 2023	Fund Letters	NCG Small Cap Growth Strategy	MEDP	Medpace Holdings	Health Care	Life Sciences Tools & Services	Bull	NASDAQ	biopharma, Clinical trials, contract research, Cro, growth, Healthcare services, life sciences, market share	Login
Dec 31, 2023	Fund Letters	NCG Small Cap Growth Strategy	BRZE	Braze	Information Technology	Application Software	Bull	NASDAQ	Cross-Channel, Customer Engagement, high margins, market disruption, Marketing Technology, platform, Real Time, SaaS	Login
Dec 31, 2023	Fund Letters	NCG Small Cap Growth Strategy	ACGL\|APH\|COO\|CSGP\|DKNG\|GWRE\|IDXX\|IOT\|IT\|LPLA\|MSCI\|MTD\|PCOR\|ROP\|TECH\|VRSK	Guidewire Software	Information Technology	Application Software	Bull	NYSE	cloud migration, Digital transformation, Insurance-software, Legacy Replacement, P&C insurance, platform, SaaS, turnaround	Login
Dec 31, 2023	Fund Letters	NCG Small Cap Growth Strategy	ARGX BB\|DAVA\|DDOG\|GLOB\|ILMN\|LOAR\|MELI\|NET\|NU\|NVDA\|TSM	Endava	Information Technology	IT Consulting & Other Services	Bull	NYSE	banking, Cyclical Recovery, Digital transformation, Fintech, IT services, Outsourcing, Payments, Telecom	Login
Dec 31, 2023	Fund Letters	NCG Small Cap Growth Strategy	NTRA	Natera	Health Care	Life Sciences Tools & Services	Bull	NASDAQ	Cell-free DNA, diagnostics, Genetic Testing, MRD Testing, NIPT, Oncology, personalized medicine, women's health	Login
Dec 31, 2023	Fund Letters	NCG Small Cap Growth Strategy	ASIC\|CWAN\|INSP\|KRMN\|KTOS\|MAC\|MEG\|RH\|WYNN	Clearwater Analytics Holdings	Information Technology	Application Software	Bull	NYSE	2021 IPO, Analytics Platform, Asset Managers, Insurance, Investment Accounting, market share gains, SaaS, valuation opportunity	Login
Dec 31, 2023	Fund Letters	NCG Small Cap Growth Strategy	TNDM	Tandem Diabetes Care	Health Care	Health Care Equipment	Bull	NASDAQ	Depressed valuation, diabetes care, Growth Reacceleration, Insulin Pump, Medical Device, New products, product innovation, turnaround	Login
Dec 31, 2023	Fund Letters	NCG Small Cap Growth Strategy	CSTL	Castle Bioscience	Health Care	Life Sciences Tools & Services	Bull	NASDAQ	Acquisitions, Cash Flow Breakeven, Compressed Valuation, Medical Diagnostics, Mental health, Oncology Testing, Skin Cancer, Under-Penetration	Login

Date

Pitch Type

Author

Ticker

Company

Industry

Sub Industry

Bull / Bear

Exchange

Keywords

Action

Oct 24, 2025

Fund Letters

Tom Press

XMTR

Xometry Inc.

Industrials

Commercial Services & Supplies

Bull

NASDAQ

AI, Automation, Digitization, growth, manufacturing, Margins, marketplace, Partnerships, Reshoring, supply chain

Oct 24, 2025

Fund Letters

Tom Press

Bloom Energy Corporation

Industrials

Renewable Electricity

Bull

NYSE

AI, backlog, energy, Fuel cells, growth, hyperscalers, infrastructure, Margins, Power, renewables

Dec 31, 2023

Fund Letters

NCG Small Cap Growth Strategy

MEDP

Medpace Holdings

Health Care

Life Sciences Tools & Services

Bull

NASDAQ

biopharma, Clinical trials, contract research, Cro, growth, Healthcare services, life sciences, market share

Dec 31, 2023

Fund Letters

NCG Small Cap Growth Strategy

BRZE

Braze

Information Technology

Application Software

Bull

NASDAQ

Cross-Channel, Customer Engagement, high margins, market disruption, Marketing Technology, platform, Real Time, SaaS

Dec 31, 2023

Fund Letters

NCG Small Cap Growth Strategy

Guidewire Software

Information Technology

Application Software

Bull

NYSE

cloud migration, Digital transformation, Insurance-software, Legacy Replacement, P&C insurance, platform, SaaS, turnaround

Dec 31, 2023

Fund Letters

NCG Small Cap Growth Strategy

Endava

Information Technology

IT Consulting & Other Services

Bull

NYSE

banking, Cyclical Recovery, Digital transformation, Fintech, IT services, Outsourcing, Payments, Telecom

Dec 31, 2023

Fund Letters

NCG Small Cap Growth Strategy

NTRA

Natera

Health Care

Life Sciences Tools & Services

Bull

NASDAQ

Cell-free DNA, diagnostics, Genetic Testing, MRD Testing, NIPT, Oncology, personalized medicine, women's health

Dec 31, 2023

Fund Letters

NCG Small Cap Growth Strategy

Clearwater Analytics Holdings

Information Technology

Application Software

Bull

NYSE

2021 IPO, Analytics Platform, Asset Managers, Insurance, Investment Accounting, market share gains, SaaS, valuation opportunity

Dec 31, 2023

Fund Letters

NCG Small Cap Growth Strategy

TNDM

Tandem Diabetes Care

Health Care

Health Care Equipment

Bull

NASDAQ

Depressed valuation, diabetes care, Growth Reacceleration, Insulin Pump, Medical Device, New products, product innovation, turnaround

Dec 31, 2023

Fund Letters

NCG Small Cap Growth Strategy

CSTL

Castle Bioscience

Health Care

Life Sciences Tools & Services

Bull

NASDAQ

Acquisitions, Cash Flow Breakeven, Compressed Valuation, Medical Diagnostics, Mental health, Oncology Testing, Skin Cancer, Under-Penetration

TICKER	COMMENTARY
No ticker commentary found.

TICKER

COMMENTARY

No ticker commentary found.

Ticker	Put/Call	Amount Bought	Shares Bought	% Change	Weight %
No Recent Buys Data

Ticker

Put/Call

Amount Bought

Shares Bought

% Change

Weight %

No Recent Buys Data

Ticker	Put/Call	Amount Sold	Shares Sold	% Change	Weight %	Status
No Recent Sells Data

Ticker

Put/Call

Amount Sold

Shares Sold

% Change

Weight %

Status

No Recent Sells Data

Industry	Prev Quarter %	Current Quarter %	Change
No industry data available

Industry

Prev Quarter %

Current Quarter %

Change

No industry data available

Investment Summary

Investor Summary

Fund Strategy

FUND PERFORMANCE AS OF 31st March 2026

Investor Letters

Latest Executive Summary:

Executive Summary

Core Thesis

Forward Outlook

Investment Themes

AI

Defense Spending

Small Caps

Critical Minerals

AI

Cloud

Pharmaceuticals

Medical Devices

Streaming

AI

Infrastructure Spending

Critical Minerals

Nuclear

Defense

Small Caps

Trade Policy

Infrastructure Spending

Rates

Infrastructure Spending

Trade Policy

Small Caps

Biotechnology

Growth

Investor Pitches

Current Portfolio as of ( 31st March 2026 )

Key Risks identified by Manager:

Key catalysts include:

Portfolio Implications

Ticker Commentary

Tom Press Top Holdings

Recent Buys (13F)

Recent Sells (13F)

13F Sector Summary

Portfolio Distribution

Latest 13D & 13G Filings

Join for free and get access to the buyside

Get insights from the world's most influential hedge fund investors direct to your inbox

Follow Us On:

Subscribe to receive email notification and updates for:

NCG Small Cap Growth Strategy